Gastroesophageal Reflux Disease Market Size, Share, Industry Trends and Forecast to 2033
This report provides an in-depth analysis of the Gastroesophageal Reflux Disease (GERD) market, covering market size, growth trends, segmentation, regional insights, and future forecasts through 2033.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $10.50 Billion |
| CAGR (2023-2033) | 5.7% |
| 2033 Market Size | $18.52 Billion |
| Top Companies | Pfizer Inc., Johnson & Johnson, Novartis AG, GSK plc |
| Last Modified Date | 15 Nov 2024 |
Gastroesophageal Reflux Disease Market Report (2023 - 2033)
Gastroesophageal Reflux Disease Market Overview
What is the Market Size & CAGR of Gastroesophageal Reflux Disease market in 2033?
Gastroesophageal Reflux Disease Industry Analysis
Gastroesophageal Reflux Disease Market Segmentation and Scope
Request a custom research report for industry.
Gastroesophageal Reflux Disease Market Analysis Report by Region
Europe Gastroesophageal Reflux Disease Market Report:
Europe's GERD market is forecasted to rise from $3.17 billion in 2023 to $5.59 billion by 2033. The presence of advanced healthcare infrastructure and ongoing research efforts in the region are supporting this growth trajectory.Asia Pacific Gastroesophageal Reflux Disease Market Report:
The Asia Pacific region is expected to experience significant growth, with the market size increasing from $2.05 billion in 2023 to $3.62 billion by 2033. This growth can be attributed to the rising prevalence of GERD, along with increasing healthcare investments and improved access to treatments.North America Gastroesophageal Reflux Disease Market Report:
North America holds a substantial share of the GERD market, expanding from $3.36 billion in 2023 to approximately $5.93 billion by 2033. The prevalence of obesity and sedentary lifestyles are key drivers for this growth in the region.South America Gastroesophageal Reflux Disease Market Report:
In South America, the GERD market is projected to grow from $0.77 billion in 2023 to $1.36 billion by 2033. Factors such as rising healthcare awareness and increasing investment in healthcare services are contributing to this market expansion.Middle East & Africa Gastroesophageal Reflux Disease Market Report:
In the Middle East and Africa, the GERD market is estimated to increase from $1.15 billion in 2023 to $2.02 billion by 2033. Growing healthcare expenditure and rising awareness about gastroenterological disorders are vital factors contributing to this growth.Request a custom research report for industry.
Gastroesophageal Reflux Disease Market Analysis By Type
Global Gastroesophageal Reflux Disease Market, By Type Market Analysis (2023 - 2033)
The GERD market segmentation by type indicates that Acid Reflux dominates the market with a size of $8.53 billion in 2023, projected to grow to $15.04 billion by 2033, capturing 81.21% of the market share. Conversely, Laryngopharyngeal Reflux has a smaller size of $1.97 billion in 2023, anticipated to reach $3.48 billion by 2033, maintaining an 18.79% share.
Gastroesophageal Reflux Disease Market Analysis By Treatment
Global Gastroesophageal Reflux Disease Market, By Treatment Market Analysis (2023 - 2033)
Medications constitute the largest segment in the treatment of GERD, estimated at $8.53 billion in 2023 and expected to grow to $15.04 billion by 2033, reflecting a significant share of 81.21% in the market. Surgical options are also prevalent, with a size of $1.97 billion in 2023 and a projected growth to $3.48 billion by 2033, holding an 18.79% share.
Gastroesophageal Reflux Disease Market Analysis By End User
Global Gastroesophageal Reflux Disease Market, By End-User Market Analysis (2023 - 2033)
In the end-user segment, hospitals remain the dominant sector, valued at $6.73 billion in 2023 and project to reach $11.86 billion by 2033, representing a 64.06% market share. Clinics and home care also play a role, with sizes of $3.01 billion and $0.77 billion in 2023 respectively, expected to reach $5.30 billion and $1.35 billion by 2033.
Gastroesophageal Reflux Disease Market Analysis By Disease Severity
Global Gastroesophageal Reflux Disease Market, By Disease Severity Market Analysis (2023 - 2033)
In terms of disease severity, Mild GERD accounts for the largest share with a market size of $6.73 billion in 2023, projected to grow to $11.86 billion by 2033, holding a 64.06% share. Moderate GERD and Severe GERD show smaller market sizes of $3.01 billion and $0.77 billion in 2023, growing to $5.30 billion and $1.35 billion by 2033, respectively.
Gastroesophageal Reflux Disease Market Analysis By Diagnosis
Global Gastroesophageal Reflux Disease Market, By Diagnosis Market Analysis (2023 - 2033)
Diagnosis methodologies are critical in managing GERD, with Endoscopy leading the market at $5.67 billion in 2023, projected to grow to $10.00 billion by 2033, holding a 53.98% market share. Esophageal Manometry, pH Monitoring, and others also contribute to the market, valued at $2.60 billion, $1.15 billion, and $1.08 billion in 2023.
Gastroesophageal Reflux Disease Market Trends and Future Forecast
Request a custom research report for industry.
Global Market Leaders and Top Companies in Gastroesophageal Reflux Disease Industry
Pfizer Inc.:
A global biopharmaceutical company, Pfizer focuses on discovering, developing, and delivering therapeutics that improve health outcomes related to GERD, including advanced medication options.Johnson & Johnson:
A leader in medical devices, pharmaceuticals, and consumer health products, Johnson & Johnson provides innovative solutions for GERD treatment through its surgical and diagnostic units.Novartis AG:
With a comprehensive portfolio of healthcare solutions, Novartis specializes in pharmaceuticals and innovative treatments for GERD, driving market growth through research and marketing efforts.GSK plc:
GSK is known for being at the forefront of drug development for GI diseases, including GERD, focusing on effective therapies and patient-centric solutions.We're grateful to work with incredible clients.
